Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gleich

Showing results (461-470 of 521) with videos related to

Pageof 53
Sort By:
JTCVS Open|January 9, 2025
Intraoperative cardiac arrest in patients undergoing congenital cardiac surgeryMorgan L Brown, Steven J Staffa, Phillip S Adams, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitisJens U Ponikau, David A Sherris, Gail M Kephart, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2006
Identification of basophils by a mAb directed against pro-major basic protein 1Douglas A Plager, Ellen A Weiss, Gail M Kephart, et al.
The Journal of Allergy and Clinical Immunology|September 13, 2000
Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffectedH Kita, R K Jorgensen, C E Reed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Major basic protein homolog (MBP2): a specific human eosinophil markerDouglas A Plager, David A Loegering, James L Checkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administrationJ A Sosman, K Bartemes, K P Offord, et al.
Nature Medicine|August 12, 2008
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defenseShida Yousefi, Jeffrey A Gold, Nicola Andina, et al.
The Journal of Biological Chemistry|July 27, 2000
Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitorM T Overgaard, J Haaning, H B Boldt, et al.
Genomics|August 1, 1990
Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamilyK J Hamann, R M Ten, D A Loegering, et al.
Archives of Pathology & Laboratory Medicine|November 11, 1992
Eosinophil-mediated bile duct stricture. A case studied by immunohistochemistryR T Schlinkert, M de la Garza-Grahm, C B Reeder, et al.
Pageof 53

Showing results (461-470 of 521) with videos related to

Sort By:
Pageof 53
JTCVS Open|January 9, 2025
Intraoperative cardiac arrest in patients undergoing congenital cardiac surgeryMorgan L Brown, Steven J Staffa, Phillip S Adams, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitisJens U Ponikau, David A Sherris, Gail M Kephart, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2006
Identification of basophils by a mAb directed against pro-major basic protein 1Douglas A Plager, Ellen A Weiss, Gail M Kephart, et al.
The Journal of Allergy and Clinical Immunology|September 13, 2000
Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffectedH Kita, R K Jorgensen, C E Reed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Major basic protein homolog (MBP2): a specific human eosinophil markerDouglas A Plager, David A Loegering, James L Checkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administrationJ A Sosman, K Bartemes, K P Offord, et al.
Nature Medicine|August 12, 2008
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defenseShida Yousefi, Jeffrey A Gold, Nicola Andina, et al.
The Journal of Biological Chemistry|July 27, 2000
Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitorM T Overgaard, J Haaning, H B Boldt, et al.
Genomics|August 1, 1990
Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamilyK J Hamann, R M Ten, D A Loegering, et al.
Archives of Pathology & Laboratory Medicine|November 11, 1992
Eosinophil-mediated bile duct stricture. A case studied by immunohistochemistryR T Schlinkert, M de la Garza-Grahm, C B Reeder, et al.
Pageof 53